Gary Schwartz: Monica Bertagnolli is poised to be a visionary NIH director

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As Case Comprehensive Cancer Center’s new director, and on behalf of our membership, I applaud the Biden administration for tapping Monica Bertagnolli, MD, FASCO, as the second female director of the National Institutes of Health (NIH) and congratulate Dr. Bertagnolli on her candidacy. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Gary Schwartz, MD
Director, Case Comprehensive Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
Gary Schwartz, MD
Director, Case Comprehensive Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login